Deutsche Börse and the London Stock Exchange Group’s plan to create Europe’s largest exchange group is set to face an in-depth investigation by Brussels following fears that the companies would have limited time to answer authorities’ initial concerns.
European antitrust officials held a meeting last Wednesday with the exchanges outlining market concerns about the deal but the watchdog has not shared its own thoughts, according to two advisers familiar with the discussions. The exchanges will probably only find out close to the end of the EU’s initial investigation on September 28, the advisers said.
The Commission is due to make public its deliberations a few days later and the limited timeframe to offer remedies — if needed — would make an in-depth study inevitable. The Commission said it would not comment on the investigation. The LSE and Deutsche Börse also declined to comment.
The combination would create one of the biggest venues for equities listings and market data, and risk manage more derivatives trades than any other entity in the world. It has already met criticism from some rival European exchanges as well as the governments of France, Belgium, the Netherlands and Portugal.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas